Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol inhalation solution for mucus in lower respiratory tract infection
CTR20250449Phase 3Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambroxol in pulmonary infection, sponsored by Hanmi Pharmaceutical. Started Feb 2025; status: completed.
02
Drugs
ambroxol
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on CTR20250449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250449.